Thyroid fine-needle aspiration reporting rates and outcomes before and after bethesda implementation within a combined academic and community hospital system Academic Article uri icon

Overview

MeSH Major

  • Biopsy, Fine-Needle
  • Thyroid Gland

abstract

  • The AUS/FLUS rate of 2.1% at our institution is at the lower range of the <7% recommended by the BSRTC, and our rate of 19% for risk of malignancy for AUS/FLUS is slightly above the BSRTC recommendation of 5% to 15%. Implementation of the BSRTC did not significantly affect our institution's reporting rates, most likely because an essentially similar classification system was employed before implementation of the BSRTC.

publication date

  • November 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.5858/arpa.2012-0366-OA

PubMed ID

  • 24168507

Additional Document Info

start page

  • 1664

end page

  • 8

volume

  • 137

number

  • 11